HUTCHMED China Ltd (LSE:HCM) — Stock Price

GBX190.00 GBX
▲ 3.26% today

HUTCHMED China Ltd (LSE:HCM) is currently trading at GBX190.00 GBX, up 3.26% today. Over the past 52 weeks, shares have ranged between GBX156.00 and GBX264.00. This page tracks HUTCHMED China Ltd's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of HUTCHMED China Ltd.

HUTCHMED China Ltd (HCM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks HUTCHMED China Ltd's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

HUTCHMED China Ltd Income Statement — Revenue, Profit & Earnings by Year

HUTCHMED China Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue GBX548.65 Million GBX630.20 Million GBX838.00 Million GBX426.41 Million GBX356.13 Million
Cost of Revenue GBX336.43 Million GBX348.88 Million GBX686.45 Million GBX311.10 Million GBX258.23 Million
Gross Profit GBX212.22 Million GBX281.32 Million GBX151.55 Million GBX115.31 Million GBX97.89 Million
Research & Development GBX163.76 Million GBX212.11 Million GBX302.00 Million GBX267.59 Million GBX207.45 Million
SG&A GBX66.72 Million GBX64.30 Million GBX79.78 Million GBX92.17 Million GBX89.30 Million
Total Operating Expenses GBX266.81 Million GBX321.93 Million GBX133.18 Million GBX523.00 Million GBX426.21 Million
Operating Income GBX-54.59 Million GBX-40.61 Million GBX18.38 Million GBX-407.69 Million GBX-328.32 Million
EBITDA GBX-41.28 Million GBX14.11 Million GBX67.27 Million GBX-401.11 Million GBX-321.13 Million
EBIT GBX-54.59 Million GBX1.76 Million GBX59.07 Million GBX-409.77 Million GBX-328.32 Million
Interest Expense GBX2.87 Million GBX2.87 Million GBX759.00K GBX652.00K GBX592.00K
Income Before Tax GBX521.47 Million GBX45.36 Million GBX105.60 Million GBX-360.67 Million GBX-155.12 Million
Income Tax Expense GBX63.63 Million GBX7.19 Million GBX4.51 Million GBX-283.00K GBX11.92 Million
Net Income GBX457.02 Million GBX37.73 Million GBX100.78 Million GBX-360.83 Million GBX-194.65 Million

HUTCHMED China Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes HUTCHMED China Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets GBX1.75 Billion GBX1.27 Billion GBX1.28 Billion GBX1.03 Billion GBX1.37 Billion
Total Current Assets GBX1.57 Billion GBX1.07 Billion GBX1.10 Billion GBX839.89 Million GBX1.21 Billion
Cash & Equivalents
Short-term Investments GBX1.29 Billion GBX682.15 Million GBX602.75 Million GBX317.72 Million GBX634.16 Million
Net Receivables GBX147.63 Million GBX167.74 Million GBX116.89 Million GBX97.99 Million GBX83.58 Million
Inventory GBX41.07 Million GBX50.40 Million GBX50.26 Million GBX56.69 Million GBX35.76 Million
Property, Plant & Equipment GBX84.67 Million GBX53.15 Million
Goodwill GBX3.11 Million GBX2.99 Million GBX3.38 Million
Total Liabilities GBX501.15 Million GBX502.34 Million GBX536.39 Million GBX392.57 Million GBX333.15 Million
Total Current Liabilities GBX315.34 Million GBX376.56 Million GBX403.03 Million GBX353.90 Million GBX311.66 Million
Long-term Debt GBX68.19 Million GBX59.43 Million GBX48.19 Million GBX18.10 Million GBX0.00
Net Debt GBX26.53 Million GBX-64.14 Million GBX-197.46 Million GBX-289.98 Million GBX-338.56 Million
Total Stockholder Equity GBX1.24 Billion GBX759.93 Million GBX730.54 Million GBX610.37 Million GBX986.89 Million
Retained Earnings GBX-378.13 Million GBX-833.17 Million GBX-870.87 Million GBX-971.48 Million GBX-610.33 Million

HUTCHMED China Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how HUTCHMED China Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow GBX-64.67 Million GBX497.00K GBX219.26 Million GBX-268.60 Million GBX-204.22 Million
Capital Expenditures GBX14.15 Million GBX17.93 Million GBX32.61 Million GBX36.66 Million GBX16.76 Million
Free Cash Flow GBX-78.82 Million GBX-17.44 Million GBX186.65 Million GBX-305.26 Million GBX-220.98 Million
Investing Cash Flow GBX-29.42 Million GBX-96.06 Million GBX-291.14 Million GBX296.59 Million GBX-306.32 Million
Financing Cash Flow GBX7.84 Million GBX-30.67 Million GBX48.66 Million GBX-82.76 Million GBX650.03 Million
Dividends Paid
Stock-Based Compensation GBX15.29 Million GBX21.61 Million GBX36.60 Million GBX30.59 Million GBX41.99 Million
Depreciation GBX13.31 Million GBX12.34 Million GBX8.21 Million GBX8.66 Million GBX7.19 Million
Change in Cash GBX-94.28 Million GBX-129.63 Million GBX-29.69 Million GBX-64.26 Million GBX141.91 Million

HUTCHMED China Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track HUTCHMED China Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 03, 2026 0.00 -0.02 +100.00%
Mar 23, 2026 0.02
Jul 29, 2025 0.52 0.28 +83.10%
May 28, 2025 0.00 0.00
Mar 19, 2025 0.01 0.01 +75.00%
Jul 31, 2024 0.00 0.05 -100.00%
Feb 28, 2024 -0.14 -0.14 +0.00%
Nov 10, 2023 0.00 0.01 -100.00%